Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Zocchi

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
JACC. Cardiovascular Imaging|June 24, 2023
Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic CardiomyopathyAhmed S Fahmy, Ethan J Rowin, Narjes Jaafar, et al.
International Journal of Cardiology|October 13, 2022
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral CenterAlessia Argirò, Mattia Zampieri, Lorenzo-Lupo Dei, et al.
European Journal of Internal Medicine|December 14, 2021
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort studyCarlo Fumagalli, Chiara Zocchi, Luigi Tassetti, et al.
Diagnostics (Basel, Switzerland)|December 22, 2023
Focus on Paediatric Restrictive Cardiomyopathy: Frequently Asked QuestionsMattia Zampieri, Chiara Di Filippo, Chiara Zocchi, et al.
Journal of the American Medical Directors Association|August 2, 2021
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and DisabilityCarlo Fumagalli, Andrea Ungar, Renzo Rozzini, et al.
Mayo Clinic Proceedings|August 6, 2021
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac AmyloidosisCarlo Fumagalli, Mattia Zampieri, Federico Perfetto, et al.
International Journal of Cardiology|August 5, 2022
Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry diseaseFrancesca Graziani, Rosa Lillo, Elena Biagini, et al.
The International Journal of Cardiovascular Imaging|January 27, 2026
Changes in CMR-derived ventricular strain, fibrosis progression and outcomes in hypertrophic cardiomyopathyAlberto Aimo, Andrea Barison, Annamaria Del Franco, et al.
International Journal of Cardiology|January 15, 2022
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathyCarlo Fumagalli, Valentina De Filippo, Chiara Zocchi, et al.
Infectious Diseases (London, England)|January 28, 2026
Factors associated with persistent symptoms after COVID-19 infection: a longitudinal study on an Italian cohort of patients discharged from hospitalCarla Amato, Paolo Iovino, Michele Spinicci, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
JACC. Cardiovascular Imaging|June 24, 2023
Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic CardiomyopathyAhmed S Fahmy, Ethan J Rowin, Narjes Jaafar, et al.
International Journal of Cardiology|October 13, 2022
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral CenterAlessia Argirò, Mattia Zampieri, Lorenzo-Lupo Dei, et al.
European Journal of Internal Medicine|December 14, 2021
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort studyCarlo Fumagalli, Chiara Zocchi, Luigi Tassetti, et al.
Diagnostics (Basel, Switzerland)|December 22, 2023
Focus on Paediatric Restrictive Cardiomyopathy: Frequently Asked QuestionsMattia Zampieri, Chiara Di Filippo, Chiara Zocchi, et al.
Journal of the American Medical Directors Association|August 2, 2021
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and DisabilityCarlo Fumagalli, Andrea Ungar, Renzo Rozzini, et al.
Mayo Clinic Proceedings|August 6, 2021
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac AmyloidosisCarlo Fumagalli, Mattia Zampieri, Federico Perfetto, et al.
International Journal of Cardiology|August 5, 2022
Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry diseaseFrancesca Graziani, Rosa Lillo, Elena Biagini, et al.
The International Journal of Cardiovascular Imaging|January 27, 2026
Changes in CMR-derived ventricular strain, fibrosis progression and outcomes in hypertrophic cardiomyopathyAlberto Aimo, Andrea Barison, Annamaria Del Franco, et al.
International Journal of Cardiology|January 15, 2022
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathyCarlo Fumagalli, Valentina De Filippo, Chiara Zocchi, et al.
Infectious Diseases (London, England)|January 28, 2026
Factors associated with persistent symptoms after COVID-19 infection: a longitudinal study on an Italian cohort of patients discharged from hospitalCarla Amato, Paolo Iovino, Michele Spinicci, et al.
Pageof 4